Literature DB >> 32637913

Radiographic Progression in Patients With Ankylosing Spondylitis According to Uveitis Based on the Observation Study of Korean Spondyloarthropathy Registry.

Hyunyi Kook1, So-Hee Jin2, Seunghun Lee3, Seung-Jin Lee4, Tae-Hwan Kim5, Tae-Jong Kim2.   

Abstract

OBJECTIVES: This study aims to investigate radiographic progression according to the presence or absence of uveitis in patients with ankylosing spondylitis (AS). PATIENTS AND METHODS: A total of 598 patients (529 males, 69 females, mean age 38.1±9.2 years; range, 18 to 73 years) from the Observation Study of Korean Spondyloarthropathy Registry who met the modified New York criteria for AS were included in this study. At baseline, all data were stratified into two groups according to the presence or absence of uveitis. Baseline and radiographic progression were assessed for five years in this registry. Modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) was read by two radiologists. Reliability was assessed using inter- and intra- class correlation coefficient for each radiograph. Comparison of mSASSS changes was analyzed by analysis of covariance model after adjusting for confounding factors.
RESULTS: The evaluation of mSASSS showed good agreement between the two readers. A total of 193 patients (32.27%) had a history of uveitis that presented at a mean age of 39.6 years, including 30 females (15.54%). There were statistically significant differences in age (p=0.01), sex (p=0.04), hip joint involvement (p<0.01), and human leukocyte antigen B27 carrier state (p=0.02) between the two groups according to uveitis. A simple comparison revealed no significant difference in mSASSS change for five years between the two groups (mean: 3.05±0.62 vs. 3.78±0.78, p=0.47). After adjusting for confounding factors in multiple comparisons by Bonferroni correction, patients with uveitis had no significant association with mSASSS change for five years (mean: 6.29±1.32 vs. 5.49±1.39, p=0.68).
CONCLUSION: Our study confirms that there is no significant association between uveitis and radiographic progression in patients with AS after adjusting for confounding factors.
Copyright © 2020, Turkish League Against Rheumatism.

Entities:  

Keywords:  Ankylosing spondylitis; radiographic progression; uveitis

Year:  2019        PMID: 32637913      PMCID: PMC7322302          DOI: 10.5606/ArchRheumatol.2020.7095

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  28 in total

1.  Factors associated with radiographic spinal involvement and hip involvement in ankylosing spondylitis.

Authors:  Hung-An Chen; Chun-Hsiung Chen; Hsien-Tzung Liao; Yeong-Jang Lin; Pei-Chih Chen; Wei-Sheng Chen; Chung-Tei Chou
Journal:  Semin Arthritis Rheum       Date:  2010-09-27       Impact factor: 5.532

Review 2.  [Magnetic resonance imaging (MRI) diagnostics in axial spondyloarthritis].

Authors:  T Witte; X Baraliakos
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

3.  Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.

Authors:  Denis Poddubnyy; Hildrun Haibel; Joachim Listing; Elisabeth Märker-Hermann; Henning Zeidler; Jürgen Braun; Joachim Sieper; Martin Rudwaleit
Journal:  Arthritis Rheum       Date:  2012-05

4.  Determinants of early radiographic progression in ankylosing spondylitis.

Authors:  Pamir Atagunduz; Sibel Zehra Aydin; Cengiz Bahadir; Burak Erer; Haner Direskeneli
Journal:  J Rheumatol       Date:  2010-09-15       Impact factor: 4.666

5.  ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis.

Authors:  Maxime Dougados; Paternotte Simon; Juergen Braun; Ruben Burgos-Vargas; Walter P Maksymowych; Joachim Sieper; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-09-09       Impact factor: 19.103

Review 6.  A review of the pathogenesis of ankylosing spondylitis.

Authors:  Elias Dakwar; Jaypal Reddy; Fernando L Vale; Juan S Uribe
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

7.  An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group.

Authors:  Percival D Sampaio-Barros; Ivanio A Pereira; Claudia Hernández-Cuevas; Alberto Berman; Ruben Burgos-Vargas; Miguel A Gutierrez; Anabela Barcelos; José E Chávez-Corrales; Mario Moreno; Daniel R Palleiro; Ricardo Saénz-Castro; Ivan Stekman; Valderilio F Azevedo; José Antonio Braga-da-Silva; Gustavo Citera; Diana Flores-Alvarado; Célio R Gonçalves; César Graf; Alejandro Nitsche; Jorge Saavedra; Antonio C Ximenes; Janitzia Vázquez-Mellado; Eduardo Collantes-Estevez
Journal:  Clin Exp Rheumatol       Date:  2013-07-29       Impact factor: 4.473

8.  Predictors of longterm outcome in ankylosing spondylitis.

Authors:  Michele F Doran; Sinead Brophy; Kirsten MacKay; Gordon Taylor; Andrei Calin
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

9.  Demographic, clinical, laboratory and treatment characteristics of spondyloarthritis patients with and without acute anterior uveitis.

Authors:  Marcelo Gehlen; Kelly Cristina Regis; Thelma Larocca Skare
Journal:  Sao Paulo Med J       Date:  2012       Impact factor: 1.044

10.  Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.

Authors:  T C Mitulescu; C Popescu; A Naie; D Predeţeanu; V Popescu; C Alexandrescu; L M Voinea
Journal:  J Med Life       Date:  2015 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.